US Taxpayers Heavily Funded the Discovery of COVID-19 Vaccines

Clin Pharmacol Ther. 2022 Mar;111(3):542-544. doi: 10.1002/cpt.2344. Epub 2021 Jul 9.

Authors

Hussain S Lalani^{1

2}, Jerry Avorn^{2

3}, Aaron S Kesselheim^{2

3}

Affiliations

¹ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
² Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
³ Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

2019-nCoV Vaccine mRNA-1273 / economics
COVID-19 Vaccines / economics*
Financing, Government*
Financing, Organized
Intellectual Property
National Institute of Allergy and Infectious Diseases (U.S.) / economics
United States
World Health Organization

Substances

COVID-19 Vaccines
2019-nCoV Vaccine mRNA-1273

Grants and funding

Arnold Ventures